These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 29056226)

  • 1. A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression.
    Gallagher MD; Posavi M; Huang P; Unger TL; Berlyand Y; Gruenewald AL; Chesi A; Manduchi E; Wells AD; Grant SFA; Blobel GA; Brown CD; Chen-Plotkin AS
    Am J Hum Genet; 2017 Nov; 101(5):643-663. PubMed ID: 29056226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort.
    van der Zee J; Van Langenhove T; Kleinberger G; Sleegers K; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Joris G; Brys J; Mattheijssens M; Peeters K; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    Brain; 2011 Mar; 134(Pt 3):808-15. PubMed ID: 21354975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
    Busch JI; Unger TL; Jain N; Tyler Skrinak R; Charan RA; Chen-Plotkin AS
    Hum Mol Genet; 2016 Jul; 25(13):2681-2697. PubMed ID: 27126638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues.
    Hu Y; Sun JY; Zhang Y; Zhang H; Gao S; Wang T; Han Z; Wang L; Sun BL; Liu G
    BMC Med; 2021 Jan; 19(1):11. PubMed ID: 33461566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM106B haplotypes have distinct gene expression patterns in aged brain.
    Ren Y; van Blitterswijk M; Allen M; Carrasquillo MM; Reddy JS; Wang X; Beach TG; Dickson DW; Ertekin-Taner N; Asmann YW; Rademakers R
    Mol Neurodegener; 2018 Jul; 13(1):35. PubMed ID: 29970152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM106B a novel risk factor for frontotemporal lobar degeneration.
    van der Zee J; Van Broeckhoven C
    J Mol Neurosci; 2011 Nov; 45(3):516-21. PubMed ID: 21614538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-Specific Effects on Brain Volume and Cognition of
    Vandebergh M; Ramos EM; Corriveau-Lecavalier N; Ramanan VK; Kornak J; Mester C; Kolander T; Brushaber DE; Staffaroni AM; Geschwind DH; Wolf AA; Kantarci K; Gendron T; Petrucelli L; Van den Broeck M; Wynants S; Baker M; Borrego-Écija S; Appleby B; Barmada S; Bozoki AC; Clark D; Darby RR; Dickerson BC; Domoto-Reilly K; Fields JA; Galasko D; Ghoshal N; Graff-Radford NR; Grant IM; Honig LS; Hsiung GR; Huey ED; Irwin DJ; Knopman DS; Kwan JY; Léger GC; Litvan I; Masdeu JC; Mendez MF; Onyike CU; Pascual B; Pressman PS; Ritter A; Roberson ED; Snyder A; Sullivan AC; Tartaglia MC; Wint D; Heuer HW; Forsberg LK; Boxer AL; Rosen HJ; Boeve BF; Rademakers R;
    Neurology; 2024 Oct; 103(8):e209832. PubMed ID: 39321401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
    Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM
    Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.
    Lang CM; Fellerer K; Schwenk BM; Kuhn PH; Kremmer E; Edbauer D; Capell A; Haass C
    J Biol Chem; 2012 Jun; 287(23):19355-65. PubMed ID: 22511793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.
    Li Z; Farias FHG; Dube U; Del-Aguila JL; Mihindukulasuriya KA; Fernandez MV; Ibanez L; Budde JP; Wang F; Lake AM; Deming Y; Perez J; Yang C; Bahena JA; Qin W; Bradley JL; Davenport R; Bergmann K; Morris JC; Perrin RJ; Benitez BA; Dougherty JD; Harari O; Cruchaga C
    Acta Neuropathol; 2020 Jan; 139(1):45-61. PubMed ID: 31456032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.
    Llibre-Guerra JJ; Lee SE; Suemoto CK; Ehrenberg AJ; Kovacs GG; Karydas A; Staffaroni A; Franca Resende EP; Kim EJ; Hwang JH; Ramos EM; Wojta KJ; Pasquini L; Pang SY; Spina S; Allen IE; Kramer J; Miller BL; Seeley WW; Grinberg LT
    Brain Pathol; 2021 Mar; 31(2):267-282. PubMed ID: 33314436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
    Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
    Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
    Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies.
    Zhou X; Nicholson AM; Ren Y; Brooks M; Jiang P; Zuberi A; Phuoc HN; Perkerson RB; Matchett B; Parsons TM; Finch NA; Lin W; Qiao W; Castanedes-Casey M; Phillips V; Librero AL; Asmann Y; Bu G; Murray ME; Lutz C; Dickson DW; Rademakers R
    Brain; 2020 Jun; 143(6):1905-1919. PubMed ID: 32504082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
    Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E
    Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.
    Perneel J; Rademakers R
    Acta Neuropathol; 2022 Nov; 144(5):807-819. PubMed ID: 36056242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.